Shigekiyo T, Kanazuka M, Aihara K, Azuma H, Ohshima Y, Horie H, Nakahira H, Takeichi T, Matsumoto T
First Department of Internal Medicine, School of Medicine, The University of Tokushima, Japan.
Int J Hematol. 2000 Aug;72(2):247-52.
To assess the risk of thrombosis in congenital dysplasminogenemia, we studied 10 unrelated families with this disorder. The probands were excluded from the analysis of data to prevent bias in the selection of subjects. Positive thrombotic histories were found in 1 of the 25 family members determined to have heterozygous congenital dysplasminogenemia and in 2 of their 41 biochemically unaffected relatives. The percentages of family members with no history of thrombosis up to a given age among subjects with and without congenital dysplasminogenemia were analyzed by the Kaplan-Meier method. No significant difference between the 2 groups was observed by generalized Wilcoxon test (P = .32) or Cox-Mantel test (P = .62). These findings suggest that heterozygous congenital dysplasminogenemia is not associated with an increased risk of thrombosis.
为评估先天性纤溶酶原异常血症患者发生血栓形成的风险,我们研究了10个患有该疾病的非亲缘家庭。先证者被排除在数据分析之外,以防止受试者选择偏倚。在确定患有杂合性先天性纤溶酶原异常血症的25名家庭成员中,有1人有血栓形成阳性病史,在其41名生化指标正常的亲属中有2人有血栓形成阳性病史。采用Kaplan-Meier法分析了有或无先天性纤溶酶原异常血症的受试者中,至特定年龄无血栓形成病史的家庭成员百分比。通过广义Wilcoxon检验(P = 0.32)或Cox-Mantel检验(P = 0.62),未观察到两组之间存在显著差异。这些发现表明,杂合性先天性纤溶酶原异常血症与血栓形成风险增加无关。